Fmr LLC Trevi Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 3,604 shares of TRVI stock, worth $12,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,604

Previous 3,535 1.95%

Holding current value

$12,397

Previous $12,000 16.67%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.44 - $3.36 $168 - $231	69 Added 1.95%	3,604 $10,000
Q1 2024 May 13, 2024	BUY	$1.3 - $3.7 $31 - $88	24 Added 0.68%	3,535 $12,000
Q4 2023 Feb 13, 2024	BUY	$1.06 - $2.05 $2,046 - $3,958	1,931 Added 122.22%	3,511 $4,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $2.47 $1,464 - $1,714	694 Added 78.33%	1,580 $3,000
Q2 2023 Aug 11, 2023	BUY	$1.8 - $3.44 $1,594 - $3,047	886 New	886 $2,000
Q3 2022 Nov 10, 2022	BUY	$1.54 - $4.28 $2.27 Million - $6.32 Million	1,476,900 Added 1774.59%	1,560,125 $2.4 Million
Q2 2022 Aug 12, 2022	BUY	$1.8 - $3.39 $149,805 - $282,132	83,225 New	83,225 $234,000

Others Institutions Holding TRVI

# of Institutions

Shares Held

54.3M

Call Options Held

15.6K

Put Options Held

View Full List

About Trevi Therapeutics, Inc.

Ticker TRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,322,500
Market Cap $201M
Description
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...

More about TRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account